Tecentriq 50242-0918

Generic: Atezolizumab

Product NDC

50242-0918

Manufacturer: Genentech, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 8, 2019
Listing Expires: December 31, 2027
Application: BLA761034

Need to source Tecentriq? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Atezolizumab	840 mg/14mL

Drug Class

Programmed Death Receptor-1 Blocking Antibody [EPC]Antibodies [CS]Antibodies

Packaging Options(1)

50242-0918-01

1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1 VIAL, SINGLE-USE

View →